Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial
Authors
Keywords
-
Journal
BIOFACTORS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-06-08
DOI
10.1002/biof.1874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
- (2022) Qian-Long Wu et al. Diabetology & Metabolic Syndrome
- Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial
- (2021) Bijan Helli et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Lipoprotein(a) and Cardiovascular Diseases
- (2021) Hannah Miksenas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial
- (2021) Arash Gholoobi et al. INFLAMMOPHARMACOLOGY
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study
- (2020) Maryam Karimi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anti-oxidant and anti-inflammatory effects of auraptene on phytohemagglutinin (PHA)-induced inflammation in human lymphocytes
- (2020) Vahid Reza Askari et al. Pharmacological Reports
- Aerobic exercise and nano-curcumin supplementation improve inflammation in elderly females with metabolic syndrome
- (2020) Ali Osali Diabetology & Metabolic Syndrome
- Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention
- (2020) Jinli Liu et al. BMC PUBLIC HEALTH
- Lipoprotein(a) and Cardiovascular Disease
- (2020) Pia R Kamstrup CLINICAL CHEMISTRY
- Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
- (2019) Seyed Ali Jazayeri-Tehrani et al. Nutrition & Metabolism
- Crocin Protects Cardiomyocytes against LPS-Induced Inflammation
- (2019) Vafa Baradaran Rahimi et al. Pharmacological Reports
- Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-γ
- (2019) Vafa Baradaran Rahimi et al. LIFE SCIENCES
- Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects
- (2019) Raghavendhar R. Kotha et al. MOLECULES
- Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
- (2019) You-Bin Lee et al. Cardiovascular Diabetology
- A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine: a randomized clinical trial study
- (2018) Mina Abdolahi et al. CNS & Neurological Disorders-Drug Targets
- Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review
- (2018) Thomas R. Einarson et al. VALUE IN HEALTH
- Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
- (2016) Ajaikumar B Kunnumakkara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
- (2015) Betül Kocaadam et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Curcumin, Inflammation, and Chronic Diseases: How Are They Linked?
- (2015) Yan He et al. MOLECULES
- Solubility Enhancement and Delivery Systems of Curcumin a Herbal Medicine: A Review
- (2014) Umme Hani et al. Current Drug Delivery
- High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
- (2013) Wolfgang Koenig INTERNATIONAL JOURNAL OF CARDIOLOGY
- Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism
- (2011) Su-Kyung Shin et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Dyslipidemia in type 2 diabetes mellitus
- (2009) Arshag D Mooradian Nature Reviews Endocrinology
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started